These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 6987847)
1. Cell markers in lymphomas and leukemias. Bowman WP; Melvin S; Mauer AM Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847 [No Abstract] [Full Text] [Related]
2. Surface markers in leukemias and lymphomas. Siegal FP; Filippa DA; Koziner B Am J Pathol; 1978 Feb; 90(2):451-60. PubMed ID: 304673 [TBL] [Abstract][Full Text] [Related]
3. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma. Bloomfield CD; Gajl-Peczalska KJ Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102 [No Abstract] [Full Text] [Related]
4. Immunologic basis for the redefinition of malignant lymphomas. Parker JW Am J Clin Pathol; 1979 Oct; 72(4 Suppl):670-86. PubMed ID: 386778 [TBL] [Abstract][Full Text] [Related]
5. Characterization and classification of rat leukemias and lymphomas by membrane markers. Moriuchi T; Kasai M; Yamaguchi H; Kobayashi H Cancer Res; 1981 May; 41(5):1938-42. PubMed ID: 6111394 [TBL] [Abstract][Full Text] [Related]
6. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease. Aisenberg AC N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365 [No Abstract] [Full Text] [Related]
7. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674 [TBL] [Abstract][Full Text] [Related]
9. Immunologic and cytochemical characterization of lymphoreticular malignancies. Grogan TM; Hicks MJ; Jolley C Ariz Med; 1981 Jul; 38(7):524-8. PubMed ID: 6168251 [No Abstract] [Full Text] [Related]
10. [Classification of leukemic cells with immunologic markers]. Shimoyama M; Minato K Nihon Rinsho; 1980 Aug; 38(8):2999-3017. PubMed ID: 7009921 [No Abstract] [Full Text] [Related]
11. Cell surface markers in leukemia: biological and clinical correlations. Thiel E Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441 [TBL] [Abstract][Full Text] [Related]
12. B-cell malignancies and differentiation antigens defined with monoclonal antibodies. Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375 [TBL] [Abstract][Full Text] [Related]
13. Non T lymphoid cells can express T cell surface characteristics: normal, HCL, and a range of leukemic B cells express T cell antigens after appropriate in vitro stimulation. Worman CP; Mills KH; Cawley JC Semin Oncol; 1984 Dec; 11(4):401-4. PubMed ID: 6334367 [No Abstract] [Full Text] [Related]
14. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173 [No Abstract] [Full Text] [Related]
17. Membrane and other phenotypes of leukemia cells. Minowada J Prog Clin Biol Res; 1983; 132E():215-27. PubMed ID: 6647470 [No Abstract] [Full Text] [Related]
18. The detection of membrane-associated complement components (C 3 and C 4) on circulating human normal and leukemic leukocytes and on cultured cells with monkey erythrocytes. Burns GF; Cawley JC Eur J Immunol; 1979 Oct; 9(10):791-6. PubMed ID: 118035 [TBL] [Abstract][Full Text] [Related]
19. Lymphocyte surface markers. Thomson AW Scott Med J; 1979 Apr; 24(2):118-20. PubMed ID: 315100 [No Abstract] [Full Text] [Related]